I don’t put much credibility in analysts PT’s because they mis so often! Hehehe
$Corvus Pharmaceuticals(CRVS.US$ But its nice to see when i do agree! Even lower by a buck 7 would still be killer gains! LMAO![]()
. ((((((. Oppenheimer analyst Jeff Jones maintains Corvus Pharma (NASDAQ:CRVS) with a Outperform and lowers the price target from $8 to $7. )))))
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
